156 related articles for article (PubMed ID: 36200960)
21. Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia.
Sekine R; Menzel S; Hähner A; Mori E; Hummel T
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):469-472. PubMed ID: 36006515
[TBL] [Abstract][Full Text] [Related]
22. Trigeminal function in patients with COVID-associated olfactory loss.
Juratli JH; Garefis K; Konstantinidis I; Hummel T
Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097
[TBL] [Abstract][Full Text] [Related]
23. Olfactory dysfunction among patients with COVID-19.
Alkholaiwi FM; Altamimi AF; Almalki HH; Almughaiseeb FA; Alsubaie SS; Alsayahi HS; Alhijli FW; Alobaishi RS; Agrawal A; Alqahtani ZA; Alotaibi FZ
Saudi Med J; 2023 Nov; 44(11):1085-1103. PubMed ID: 37926445
[TBL] [Abstract][Full Text] [Related]
24. Well-being in patients with olfactory dysfunction.
Mai Y; Menzel S; Cuevas M; Haehner A; Hummel T
Physiol Behav; 2022 Oct; 254():113899. PubMed ID: 35809697
[TBL] [Abstract][Full Text] [Related]
25. More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis.
Parma V; Ohla K; Veldhuizen MG; Niv MY; Kelly CE; Bakke AJ; Cooper KW; Bouysset C; Pirastu N; Dibattista M; Kaur R; Liuzza MT; Pepino MY; Schöpf V; Pereda-Loth V; Olsson SB; Gerkin RC; Rohlfs Domínguez P; Albayay J; Farruggia MC; Bhutani S; Fjaeldstad AW; Kumar R; Menini A; Bensafi M; Sandell M; Konstantinidis I; Di Pizio A; Genovese F; Öztürk L; Thomas-Danguin T; Frasnelli J; Boesveldt S; Saatci Ö; Saraiva LR; Lin C; Golebiowski J; Hwang LD; Ozdener MH; Guàrdia MD; Laudamiel C; Ritchie M; Havlícek J; Pierron D; Roura E; Navarro M; Nolden AA; Lim J; Whitcroft KL; Colquitt LR; Ferdenzi C; Brindha EV; Altundag A; Macchi A; Nunez-Parra A; Patel ZM; Fiorucci S; Philpott CM; Smith BC; Lundström JN; Mucignat C; Parker JK; van den Brink M; Schmuker M; Fischmeister FPS; Heinbockel T; Shields VDC; Faraji F; Santamaría E; Fredborg WEA; Morini G; Olofsson JK; Jalessi M; Karni N; D'Errico A; Alizadeh R; Pellegrino R; Meyer P; Huart C; Chen B; Soler GM; Alwashahi MK; Welge-Lüssen A; Freiherr J; de Groot JHB; Klein H; Okamoto M; Singh PB; Hsieh JW; ; Reed DR; Hummel T; Munger SD; Hayes JE
Chem Senses; 2020 Oct; 45(7):609-622. PubMed ID: 32564071
[TBL] [Abstract][Full Text] [Related]
26. Olfaction and anosmia: From ancient times to COVID-19.
Mathis S; Le Masson G; Soulages A; Duval F; Carla L; Vallat JM; Solé G
J Neurol Sci; 2021 Jun; 425():117433. PubMed ID: 33848701
[TBL] [Abstract][Full Text] [Related]
27. [Loss of smell, a preliminary indicator of COVID-19].
Waizel-Haiat S; Waizel-Bucay J
Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):4-6. PubMed ID: 33666408
[TBL] [Abstract][Full Text] [Related]
28. Parosmia and Phantosmia: Managing Quality Disorders.
Altundag A
Curr Otorhinolaryngol Rep; 2023; 11(1):19-26. PubMed ID: 36721659
[TBL] [Abstract][Full Text] [Related]
29. Development and Validation of the Parosmia Olfactory Dysfunction Outcomes Rating (DisODOR).
Ioerger P; Kallogjeri D; Roland L; Schneider JS; Piccirillo JF; Farrell NF
Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1654-1661. PubMed ID: 37622602
[TBL] [Abstract][Full Text] [Related]
30. Severe chemotherapy-induced parosmia.
Müller A; Landis BN; Platzbecker U; Holthoff V; Frasnelli J; Hummel T
Am J Rhinol; 2006; 20(4):485-6. PubMed ID: 16955785
[TBL] [Abstract][Full Text] [Related]
31. Hyperosmia after COVID-19: hedonic perception or hypersensitivity?
Di Stadio A; D'Ascanio L; De Luca P; Roccamatisi D; La Mantia I; Brenner MJ
Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2196-2200. PubMed ID: 35363370
[TBL] [Abstract][Full Text] [Related]
32. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
Liu DT; Prem B; Besser G; Renner B; Mueller CA
Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
Laryngoscope; 2024 Apr; ():. PubMed ID: 38578016
[TBL] [Abstract][Full Text] [Related]
34. Objective evaluation of odor loss in COVID-19 and other suspected cases.
Seden N; Yiğit E; Yiğit Ö; Kaygısız İ
Am J Otolaryngol; 2021; 42(1):102761. PubMed ID: 33080550
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors of olfactory dysfunction.
Hummel T; Lötsch J
Arch Otolaryngol Head Neck Surg; 2010 Apr; 136(4):347-51. PubMed ID: 20403850
[TBL] [Abstract][Full Text] [Related]
36. The Importance of Considering Olfactory Dysfunction During the COVID-19 Pandemic and in Clinical Practice.
Desai M; Oppenheimer J
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):7-12. PubMed ID: 33130145
[TBL] [Abstract][Full Text] [Related]
37. Six month follow-up of self-reported loss of smell during the COVID-19 pandemic.
Hopkins C; Surda P; Vaira LA; Lechien JR; Safarian M; Saussez S; Kumar N
Rhinology; 2021 Feb; 59(1):26-31. PubMed ID: 33320115
[TBL] [Abstract][Full Text] [Related]
38. Phantom smells: a prevalent COVID-19 symptom that progressively sets in.
Bousquet C; Bouchoucha K; Bensafi M; Ferdenzi C
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1219-1229. PubMed ID: 36173444
[TBL] [Abstract][Full Text] [Related]
39. Olfactory Function and Olfactory Disorders.
Hummel T; Power Guerra N; Gunder N; Hähner A; Menzel S
Laryngorhinootologie; 2023 May; 102(S 01):S67-S92. PubMed ID: 37130532
[TBL] [Abstract][Full Text] [Related]
40. Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection.
Shiga H; Okuda K; Taki J; Watanabe N; Tonami H; Kinuya S; Miwa T
Int Forum Allergy Rhinol; 2019 Nov; 9(11):1252-1256. PubMed ID: 31356735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
